References
- Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1– > 3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–659
- Pickering JW, Sant HW, Bowles CAP, Roberts WL, Woods GL. Evaluation of a (1– > 3)-{beta}-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957–5962
- Wheat LJ, Witt J, III, Durkin M, Connolly P. Reduction in false antigenemia in the second generation Histoplasma antigen assay. Med Mycol 2007; 45: 169–171
- Digby J, Kalbfleisch J, Glenn A, et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003; 10: 882–885
- Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 2007; 131: 1173–1180
- Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997; 24: 1169–1171